Active substances
Fluocinolone + Neomycin
- SFDA 4
- US FDA 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DERMOLAR-N | 0.025, 0.5 % | Cream · Topical | 1 Tube | SAR 7.65 | NCE · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| PETRALAR-N CREAM | 0.025, 0.035 % | Cream · Topical | 1 Tube | SAR 6.70 | NCE · Prescription | ARAB CENTER FOR PHARMACEUTICALS & CHEMICAL IND. CO. | Withdrawn by regulatory authority · Not Marketed |
| SYNALAR N CREAM | 0.025, 0.5 % | Cream · Topical | 1 Tube | SAR 10.15 | NCE · Prescription | GRUNENTHAL | Withdrawn by MAH · Not Marketed |
| SYNALAR N OINTMENT | 0.025, 0.5 % | Ointment · Topical | 1 Tube | SAR 10.15 | NCE · Prescription | GRUNENTHAL | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NEO-SYNALAR | 0.025%;EQ 3.5MG BASE/GM | cream · topical | EUROFARMA | Prescription | 11 Jun 1963 |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.